Are we losing good drugs?

Clinical Pediatrics

Volumn 40, Issue 6, 2001, Pages 325-326

  Berlin, C ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; DIETHYLCARBAMAZINE; DILOXANIDE; DIPYRONE; EFLORNITHINE; HALOFANTRINE; IBUPROFEN; MEPACRINE; NICLOSAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PRAZIQUANTEL; QUININE;

AGRANULOCYTOSIS; AMEBIASIS; ANTIPYRETIC ACTIVITY; CESTODIASIS; DRUG APPROVAL; DRUG EXPOSURE; DRUG SCREENING; EDITORIAL; FEVER; FOOD AND DRUG ADMINISTRATION; GIARDIASIS; HUMAN; MALARIA; PEDIATRICS; RISK ASSESSMENT; SCHISTOSOMIASIS; TRYPANOSOMIASIS; UNITED STATES;

EID: 0034957568     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280104000603     Document Type: Editorial

References (8)

1. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: Results of a multinational, randomized, modified double blind study
2. Agranulocystosis induced by dipyrone, a hazardous antipyretic and analgesic
3. International agranulocystosis and aplastic anemia study. A first report of their relation to drug use with special reference to analgesics
4. Agranulocystosis and dipyrone
5. Comparative safety evaluation of non-narcotic analgesics
6. The pursuit if clinical truth: Role of epidemiology/observation studies
7. The disappearing arsenal of antiparasitic drugs
8. Guidelines for the ethical conduct of studies to evaluate drugs in the pediatric populations